HK1035136A1 - Composition comprising il-18 and topotecan for treatment and/or prevention of cancer - Google Patents

Composition comprising il-18 and topotecan for treatment and/or prevention of cancer

Info

Publication number
HK1035136A1
HK1035136A1 HK01105775A HK01105775A HK1035136A1 HK 1035136 A1 HK1035136 A1 HK 1035136A1 HK 01105775 A HK01105775 A HK 01105775A HK 01105775 A HK01105775 A HK 01105775A HK 1035136 A1 HK1035136 A1 HK 1035136A1
Authority
HK
Hong Kong
Prior art keywords
topotecan
cancer
prevention
treatment
composition
Prior art date
Application number
HK01105775A
Other languages
English (en)
Inventor
Randall K Johnson
Original Assignee
Smithkline Beecham Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=22199389&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=HK1035136(A1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Smithkline Beecham Corp filed Critical Smithkline Beecham Corp
Publication of HK1035136A1 publication Critical patent/HK1035136A1/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/19—Cytokines; Lymphokines; Interferons
    • A61K38/20—Interleukins [IL]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Immunology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Peptides Or Proteins (AREA)
HK01105775A 1998-05-21 2001-08-16 Composition comprising il-18 and topotecan for treatment and/or prevention of cancer HK1035136A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US8656098P 1998-05-21 1998-05-21
PCT/US1999/011160 WO1999059565A1 (en) 1998-05-21 1999-05-20 Novel compositions

Publications (1)

Publication Number Publication Date
HK1035136A1 true HK1035136A1 (en) 2001-11-16

Family

ID=22199389

Family Applications (1)

Application Number Title Priority Date Filing Date
HK01105775A HK1035136A1 (en) 1998-05-21 2001-08-16 Composition comprising il-18 and topotecan for treatment and/or prevention of cancer

Country Status (28)

Country Link
US (1) US6582689B1 (de)
EP (1) EP1079818B1 (de)
JP (1) JP4283998B2 (de)
KR (1) KR100624588B1 (de)
CN (1) CN1227027C (de)
AR (1) AR019844A1 (de)
AT (1) ATE245440T1 (de)
AU (1) AU750918B2 (de)
BR (1) BR9910622A (de)
CA (1) CA2328603A1 (de)
CO (1) CO5050337A1 (de)
CZ (1) CZ300496B6 (de)
DE (1) DE69909781T2 (de)
DK (1) DK1079818T3 (de)
ES (1) ES2204164T3 (de)
GC (1) GC0000102A (de)
HK (1) HK1035136A1 (de)
HU (1) HUP0600520A2 (de)
IL (2) IL139733A0 (de)
MY (1) MY123434A (de)
NO (1) NO329195B1 (de)
NZ (1) NZ508115A (de)
PL (1) PL200840B1 (de)
PT (1) PT1079818E (de)
TR (1) TR200003453T2 (de)
TW (1) TWI227136B (de)
WO (1) WO1999059565A1 (de)
ZA (1) ZA200006675B (de)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7524488B2 (en) 2001-03-08 2009-04-28 Ares Trading S.A. Interleukin-18 mutants
US20050079153A1 (en) * 2002-08-14 2005-04-14 Pfizer Inc. Methods for enhancing immune functions in neonatal mammals by administration of IL-18
AU2003295331A1 (en) * 2002-09-19 2004-04-23 Centocor, Inc. Method of inducing maturation of dendritic cells and uses therefor
AU2005277404A1 (en) * 2004-08-20 2006-03-02 Smithkline Beecham Corporation Methods of healing wounds by administering human IL-18
US20100061958A1 (en) * 2006-09-14 2010-03-11 The Trustees Of The University Of Pennsylvania Modulation of Regulatory T Cells by Human IL-18
AR065803A1 (es) * 2007-03-23 2009-07-01 Smithkline Beecham Corp Uso de un polipeptido de il- 18 humana y un anticuerpo anti- cd para preparar unmedicamento
GB0803352D0 (en) 2008-02-22 2008-04-02 Ntnu Technology Transfer As Oligopeptidic compounds and uses thereof
US8168165B2 (en) * 2008-12-23 2012-05-01 Abbott Laboratories Alkylated interleukin-18 compositions
TW201506402A (zh) * 2013-08-15 2015-02-16 Tonyar Biotech Inc 自體防潮的檢驗芯片及其製造方法
IL272635B2 (en) * 2017-09-06 2024-02-01 Univ Yale Variants of interleukin-18 and methods of use
JP2023550545A (ja) 2020-11-02 2023-12-01 シムハ・アイエル－１８・インコーポレイテッド インターロイキン－１８バリアントおよび使用の方法

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2697752B1 (fr) * 1992-11-10 1995-04-14 Rhone Poulenc Rorer Sa Compositions antitumorales contenant des dérivés du taxane.
US6207641B1 (en) * 1995-03-10 2001-03-27 Kabushiki Kaisha Hayashibara Seibutsu Kagaku Kenkyujo Pharmaceutical composition containing IFN-γ inducing polypeptide or factor for treating and/or preventing IFN-γ susceptive diseases
TW581771B (en) * 1994-11-15 2004-04-01 Hayashibara Biochem Lab Recombinant production of a polypeptide for inducing interferon-gamma production, and monoclonal antibody against the polypeptide
JP4004088B2 (ja) * 1995-09-26 2007-11-07 株式会社林原生物化学研究所 免疫担当細胞においてインターフェロン−γの産生を誘導する蛋白質
US5869535A (en) * 1995-03-21 1999-02-09 The Board Of Trustees Of The University Of Illinois Method and composition for selectively inhibiting melanoma
JP4024366B2 (ja) * 1996-11-29 2007-12-19 株式会社林原生物化学研究所 ポリペプチド

Also Published As

Publication number Publication date
EP1079818A1 (de) 2001-03-07
CA2328603A1 (en) 1999-11-25
AU4309499A (en) 1999-12-06
WO1999059565A1 (en) 1999-11-25
DE69909781D1 (de) 2003-08-28
EP1079818B1 (de) 2003-07-23
GC0000102A (en) 2005-06-29
AR019844A1 (es) 2002-03-20
TWI227136B (en) 2005-02-01
JP4283998B2 (ja) 2009-06-24
HUP0600520A2 (en) 2006-10-28
CZ20004321A3 (en) 2001-05-16
TR200003453T2 (tr) 2001-10-22
IL139733A (en) 2009-06-15
ZA200006675B (en) 2002-02-27
NO329195B1 (no) 2010-09-13
US6582689B1 (en) 2003-06-24
ATE245440T1 (de) 2003-08-15
CZ300496B6 (cs) 2009-06-03
BR9910622A (pt) 2001-01-30
CN1367686A (zh) 2002-09-04
EP1079818A4 (de) 2001-12-12
NZ508115A (en) 2003-12-19
JP2003509333A (ja) 2003-03-11
DK1079818T3 (da) 2004-04-19
PL200840B1 (pl) 2009-02-27
CN1227027C (zh) 2005-11-16
PT1079818E (pt) 2004-02-27
ES2204164T3 (es) 2004-04-16
MY123434A (en) 2006-05-31
KR20010052369A (ko) 2001-06-25
NO20005857D0 (no) 2000-11-20
KR100624588B1 (ko) 2006-09-18
DE69909781T2 (de) 2004-05-27
CO5050337A1 (es) 2001-06-27
IL139733A0 (en) 2002-02-10
NO20005857L (no) 2000-11-21
AU750918B2 (en) 2002-08-01
PL366170A1 (en) 2005-01-24

Similar Documents

Publication Publication Date Title
HUP0103920A3 (en) Methods and compositions for the prevention and treatment of anemia
AU6147401A (en) Compositions and methods for the treatment of cancer
PL349322A1 (en) Compositions and methods for therapy and diagnosis of ovarian cancer
IL140845A0 (en) Compositions for therapy and diagnosis of prostate cancer
GB9903841D0 (en) Diagnosis and treatment of cancer
AU2212299A (en) Compositions and methods for the treatment of tumor
HUP0104688A3 (en) Compositions and methods for the prevention or treatment of cancer and bone loss associated with cancer
KR100510795B1 (en) Compositions and Methods for the Treatment of Tumor
PL352931A1 (en) Compositions and uses of et743 for treating cancer
EP1379242A4 (de) Verfahren zur behandlung von krebs und dafür verwendbare zusammensetzungen
IL158206A0 (en) Compositions and methods for the prevention and treatment of human prostate cancer
HK1035136A1 (en) Composition comprising il-18 and topotecan for treatment and/or prevention of cancer
IL124650A0 (en) Methods and therapeutic compositions for treating cancer
IL145397A0 (en) Compositions and methods for treatment of cancer
GB9811598D0 (en) Diagnosis and treatment of cancer
IL141426A0 (en) Compositions and methods for the treatment of tumor
IL132094A0 (en) Methods and compositions for treatment of ovarian cancer
PL368035A1 (en) Compositions and methods for the treatment of cancer
IL143212A0 (en) Compositions and methods for the treatment of tumor
IL154354A0 (en) Composition for prophylaxis and treatment of cancer
IL147410A0 (en) L-acetylcarnitine and l-propionylcarnitine containing composition for the prevention and treatment of kidney dysfunctions and diseases
EP1423118A4 (de) Verfahren und zusammensetzung für die krebsbehandlung
GB9819999D0 (en) Treatment of cancer
AU5097099A (en) Methods and compositions for cancer treatment
EP0929540A4 (de) Antitumor-zusamensetzungen und behandlungsverfahren

Legal Events

Date Code Title Description
PF Patent in force
PC Patent ceased (i.e. patent has lapsed due to the failure to pay the renewal fee)

Effective date: 20140520